Recipient
Ottawa Hospital Research InstituteDepartment
National Research Council CanadaAmount
$355.9K
Province
ONType
G
Agreement Number
992639
Purpose
This project will support process and assay development efforts currently ongoing at the NRC for an adeno-associated virus (AAV)-based next generation LPLD gene therapy. The goal of this project will be to accelerate the rate at which this therapy is GMP manufactured and subsequently ready to be tested in the clinic, by formally combining the efforts, experience and expertise of both the NRC and BMC-VMF to finalize process parameters and develop and qualify key GMP release tests that will be executed at the BMC.
Ottawa Hospital Research Institute × National Research Council Canada
13 grants totalling $7.0M
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
1,000 grants totalling $348.9M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| The Governing Council of the University of Toronto | $3.0M | Collaborative Science, Technology and In... |